Facing bipartisan hostility over high drug prices in an election year, the pharma industry’s biggest trade group boosted revenue by nearly a fourth last year and spread the millions collected among hundreds of lobbyists, politicians and patient groups, new filings show.
It was the biggest surge for the Pharmaceutical Research and Manufacturers of America, known as PhRMA, since the group took battle stations to advance its interests in 2009 during the run-up to the Affordable Care Act.
Not to mention nearly 6 billion for marketing plus the median pay for the top twenty pharma ceo’s is approximately 30 million a year. That’s your healthcare dollar at work.
Comments are closed.